Investor Relations

OPKO Announces First Quarter 2013 Operating and Financial Highlights more »

OPKO Health To Acquire PROLOR Biotech more »

OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company more »

OPKO Health Announces Publication of Study Detecting Antibodies in NMO Patients Using OPKO Screening Technology more »

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put OPKO Health, Inc.'s financial performance into perspective.

  • Events

Jan 8, 2013 - 4:00 PM PT
OPKO Health to Present at the 31st Annual J.P. Morgan Healthcare Conference
PDF View OPKO Health Presentation
OPKO Health to Acquire Two Phase 3 Products
PDF View Cytochroma Presentation

  • Stock Information


Ticker OPK Exchange NYSE
Last Price 7.16 Change 0.15 up
Open 7.05 Previous Close 7.01
Day High 7.16 Day Low 7.00
52-Week High 7.83 52-Week Low 4.00
Quotes delayed at least 20 minutes. Information provided by eSignal.